X-Square Capital’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

X-Square Capital’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-51,517	Closed	-$1.21M	–	146
2021 Q1	$1.21M	Buy	51,517 +2,148	+4%	+$65.1K	0.56%	51
2020 Q4	$1.42M	Hold	49,369	–	–	0.77%	35
2020 Q3	$1M	Sell	49,369 -4,581	-8%	-$112K	0.72%	44
2020 Q2	$1.62M	Buy	53,950 +7,010	+15%	+$252K	1.15%	21
2020 Q1	$1.48M	Buy	46,940 +3,310	+8%	+$115K	1.47%	21
2019 Q4	$2.06M	Buy	+43,630	New	+$1.26M	1.21%	21

Other funds holding CNST

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return

OPU

Omni Partners US Irvine, California $1.95B AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

PIM

Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

X-Square Capital's CNST Position: Q2 2021 in Review

X-Square Capital sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 51,517 shares — an estimated $1.21M sold.

X-Square Capital first reported a position in CNST in Q4 2019 and held it in 6 quarters. The position peaked at $2.06M in Q4 2019. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

X-Square Capital reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
X-Square Capital sold 51,517 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $1.21M.
X-Square Capital first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 6 quarters.
X-Square Capital's Constellation Pharmaceuticals, Inc. position peaked at $2.06M in Q4 2019.
153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on X-Square Capital's 13F filing for Q2 2021, filed 16 Aug 2021.